Top

Published in:

01-08-2019 | Review

T-cell aging in end-stage renal disease: an evolving story with CMV

Authors: TienYu Owen Yang, Yi-Fang Chuang, Yen-Ling Chiu

Published in: Medical Microbiology and Immunology | Issue 3-4/2019

Abstract

Established evidence from the last decade has suggested that chronic cytomegalovirus infection has strong impact on the human immune system, resulting in aggravated aging-associated T-cell changes that are associated with poorer vaccination responses, cardiovascular disease and shortened survival. Patients with end-stage renal disease (ESRD), the most severe form of chronic kidney disease, exhibit premature aging phenotypes in almost all organ systems, including the immune system. Longitudinal studies of T-cell aging in healthy humans have been scanty because it requires a large number of study subjects and a study duration for decades. In recent years, it became clear that ESRD patients with cytomegalovirus (CMV) infection exhibit enhanced aging-related immune changes than CMV-seropositive individuals without renal disease, including chronic inflammation, decreased numbers of naïve CD4+ and CD8+ T cells, increased clonality of memory T cells with skewed repertoire and shortened telomeres. These findings lead to the hypothesis that the uremic milieu and treatment for renal failure can lead to premature aging of T cells independent from CMV infection and suggest that ESRD can be an important disease model for studying human aging. Future studies deciphering the underlying mechanisms of accelerated T cell aging in ESRD patients may eventually reveal additional insights into T-cell persistence and function during aging in CMV-seropositive, non-ESRD individuals.

Sansoni P, Vescovini R, Fagnoni FF, Akbar A, Arens R, Chiu YL, Cicin-Sain L, Dechanet-Merville J, Derhovanessian E, Ferrando-Martinez S, Franceschi C, Frasca D, Fulop T, Furman D, Gkrania-Klotsas E, Goodrum F, Grubeck-Loebenstein B, Hurme M, Kern F, Lilleri D, Lopez-Botet M, Maier AB, Marandu T, Marchant A, Mathei C, Moss P, Muntasell A, Remmerswaal EB, Riddell NE, Rothe K, Sauce D, Shin EC, Simanek AM, Smithey MJ, Soderberg-Naucler C, Solana R, Thomas PG, van Lier R, Pawelec G, Nikolich-Zugich J (2014) New advances in CMV and immunosenescence. Exp Gerontol. https://doi.org/10.1016/j.exger.2014.03.020 CrossRefPubMedPubMedCentral

Simanek AM, Dowd JB, Pawelec G, Melzer D, Dutta A, Aiello AE (2011) Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS One 6(2):e16103. https://doi.org/10.1371/journal.pone.0016103 CrossRefPubMedPubMedCentral

Lachmann R, Loenenbach A, Waterboer T, Brenner N, Pawlita M, Michel A, Thamm M, Poethko-Muller C, Wichmann O, Wiese-Posselt M (2018) Cytomegalovirus (CMV) seroprevalence in the adult population of Germany. PLoS One 13(7):e0200267. https://doi.org/10.1371/journal.pone.0200267 CrossRefPubMedPubMedCentral

Thomas B, Wulf S, Bikbov B, Perico N, Cortinovis M, Courville de Vaccaro K, Flaxman A, Peterson H, Delossantos A, Haring D, Mehrotra R, Himmelfarb J, Remuzzi G, Murray C, Naghavi M (2015) Maintenance dialysis throughout the world in years 1990 and 2010. J Am Soc Nephrol 26(11):2621–2633. https://doi.org/10.1681/ASN.2014101017 CrossRefPubMedPubMedCentral

Kooman JP, Kotanko P, Schols AM, Shiels PG, Stenvinkel P (2014) Chronic kidney disease and premature ageing. Nat Rev Nephrol 10(12):732–742. https://doi.org/10.1038/nrneph.2014.185 CrossRefPubMed

Fulop T, Larbi A, Pawelec G (2013) Human T cell aging and the impact of persistent viral infections. Front Immunol 4:271. https://doi.org/10.3389/fimmu.2013.00271 CrossRefPubMedPubMedCentral

Akbar AN, Vukmanovic-Stejic M (2007) Telomerase in T lymphocytes: use it and lose it? J Immunol 178(11):6689–6694CrossRef

Sylwester AW, Mitchell BL, Edgar JB, Taormina C, Pelte C, Ruchti F, Sleath PR, Grabstein KH, Hosken NA, Kern F, Nelson JA, Picker LJ (2005) Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 202(5):673–685. https://doi.org/10.1084/jem.20050882 CrossRefPubMedPubMedCentral

Czesnikiewicz-Guzik M, Lee WW, Cui D, Hiruma Y, Lamar DL, Yang ZZ, Ouslander JG, Weyand CM, Goronzy JJ (2008) T cell subset-specific susceptibility to aging. Clin Immunol 127(1):107–118. https://doi.org/10.1016/j.clim.2007.12.002 CrossRefPubMedPubMedCentral

10.

Weinberger B, Lazuardi L, Weiskirchner I, Keller M, Neuner C, Fischer KH, Neuman B, Wurzner R, Grubeck-Loebenstein B (2007) Healthy aging and latent infection with CMV lead to distinct changes in CD8+ and CD4+ T-cell subsets in the elderly. Hum Immunol 68(2):86–90. https://doi.org/10.1016/j.humimm.2006.10.019 CrossRefPubMed

11.

Wertheimer AM, Bennett MS, Park B, Uhrlaub JL, Martinez C, Pulko V, Currier NL, Nikolich-Zugich D, Kaye J, Nikolich-Zugich J (2014) Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans. J Immunol 192(5):2143–2155. https://doi.org/10.4049/jimmunol.1301721 CrossRefPubMedPubMedCentral

12.

Fagnoni FF, Vescovini R, Passeri G, Bologna G, Pedrazzoni M, Lavagetto G, Casti A, Franceschi C, Passeri M, Sansoni P (2000) Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. Blood 95(9):2860–2868CrossRef

13.

Goronzy JJ, Weyand CM (2017) Successful and maladaptive T cell aging. Immunity 46(3):364–378. https://doi.org/10.1016/j.immuni.2017.03.010 CrossRefPubMedPubMedCentral

14.

Le Saux S, Weyand CM, Goronzy JJ (2012) Mechanisms of immunosenescence: lessons from models of accelerated immune aging. Ann N Y Acad Sci 1247:69–82. https://doi.org/10.1111/j.1749-6632.2011.06297.x CrossRefPubMedPubMedCentral

15.

Pita-Lopez ML, Gayoso I, DelaRosa O, Casado JG, Alonso C, Munoz-Gomariz E, Tarazona R, Solana R (2009) Effect of ageing on CMV-specific CD8 T cells from CMV seropositive healthy donors. Immun Ageing 6:11. https://doi.org/10.1186/1742-4933-6-11 CrossRefPubMedPubMedCentral

16.

Libri V, Azevedo RI, Jackson SE, Di Mitri D, Lachmann R, Fuhrmann S, Vukmanovic-Stejic M, Yong K, Battistini L, Kern F, Soares MV, Akbar AN (2011) Cytomegalovirus infection induces the accumulation of short-lived, multifunctional CD4+ CD45RA + CD27 + T cells: the potential involvement of interleukin-7 in this process. Immunology 132(3):326–339. https://doi.org/10.1111/j.1365-2567.2010.03386.x CrossRefPubMedPubMedCentral

17.

Meijers RW, Litjens NH, de Wit EA, Langerak AW, van der Spek A, Baan CC, Weimar W, Betjes MG (2013) Cytomegalovirus contributes partly to uraemia-associated premature immunological ageing of the T cell compartment. Clin Exp Immunol 174(3):424–432. https://doi.org/10.1111/cei.12188 CrossRefPubMedPubMedCentral

18.

Litjens NH, de Wit EA, Betjes MG (2011) Differential effects of age, cytomegalovirus-seropositivity and end-stage renal disease (ESRD) on circulating T lymphocyte subsets. Immun Ageing 8(1):2. https://doi.org/10.1186/1742-4933-8-2 CrossRefPubMedPubMedCentral

19.

Huang L, Langerak AW, Baan CC, Litjens NH, Betjes MG (2016) Latency for cytomegalovirus impacts T cell ageing significantly in elderly end-stage renal disease patients. Clin Exp Immunol 186(2):239–248. https://doi.org/10.1111/cei.12846 CrossRefPubMedPubMedCentral

20.

Betjes MG, Langerak AW, van der Spek A, de Wit EA, Litjens NH (2011) Premature aging of circulating T cells in patients with end-stage renal disease. Kidney Int 80(2):208–217. https://doi.org/10.1038/ki.2011.110 CrossRefPubMed

21.

Chiu YL, Shu KH, Yang FJ, Chou TY, Chen PM, Lay FY, Pan SY, Lin CJ, Litjens NHR, Betjes MGH, Bermudez S, Kao KC, Chia JS, Wang G, Peng YS, Chuang YF (2018) A comprehensive characterization of aggravated aging-related changes in T lymphocytes and monocytes in end-stage renal disease: the iESRD study. Immun Ageing 15:27. https://doi.org/10.1186/s12979-018-0131-x CrossRefPubMedPubMedCentral

22.

Ducloux D, Legendre M, Bamoulid J, Rebibou JM, Saas P, Courivaud C, Crepin T (2018) ESRD-associated immune phenotype depends on dialysis modality and iron status: clinical implications. Immun Ageing 15:16. https://doi.org/10.1186/s12979-018-0121-z CrossRefPubMedPubMedCentral

23.

Wu IW, Hsu KH, Hsu HJ, Lee CC, Sun CY, Tsai CJ, Wu MS (2012) Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients—a prospective cohort study. Nephrol Dial Transplant 27(3):1169–1175. https://doi.org/10.1093/ndt/gfr453 CrossRefPubMed

24.

Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, Argiles A, European Uremic Toxin Work G (2012) Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol 23(7):1258–1270. https://doi.org/10.1681/ASN.2011121175 CrossRefPubMedPubMedCentral

25.

Huang L, Langerak AW, Wolvers-Tettero IL, Meijers RW, Baan CC, Litjens NH, Betjes MG (2015) End stage renal disease patients have a skewed T cell receptor Vbeta repertoire. Immun Ageing 12:28. https://doi.org/10.1186/s12979-015-0055-7 CrossRefPubMedPubMedCentral

26.

Huang L, Betjes MGH, Klepper M, Langerak AW, Baan CC, Litjens NHR (2017) End-stage renal disease causes skewing in the TCR Vbeta-repertoire primarily within CD8(+) T cell subsets. Front Immunol 8:1826. https://doi.org/10.3389/fimmu.2017.01826 CrossRefPubMedPubMedCentral

27.

Betjes MG, Huisman M, Weimar W, Litjens NH (2008) Expansion of cytolytic CD4+ CD28− T cells in end-stage renal disease. Kidney Int 74(6):760–767. https://doi.org/10.1038/ki.2008.301 CrossRefPubMed

28.

Foley RN, Parfrey PS, Sarnak MJ (1998) Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9(12 Suppl):S16–S23PubMed

29.

Olson NC, Doyle MF, Jenny NS, Huber SA, Psaty BM, Kronmal RA, Tracy RP (2013) Decreased naive and increased memory CD4(+) T cells are associated with subclinical atherosclerosis: the multi-ethnic study of atherosclerosis. PLoS One 8(8):e71498. https://doi.org/10.1371/journal.pone.0071498 CrossRefPubMedPubMedCentral

30.

Ammirati E, Cianflone D, Vecchio V, Banfi M, Vermi AC, De Metrio M, Grigore L, Pellegatta F, Pirillo A, Garlaschelli K, Manfredi AA, Catapano AL, Maseri A, Palini AG, Norata GD (2012) Effector memory T cells are associated with atherosclerosis in humans and animal models. J Am Heart Assoc 1(1):27–41. https://doi.org/10.1161/JAHA.111.000125 CrossRefPubMedPubMedCentral

31.

van de Berg PJ, Yong SL, Remmerswaal EB, van Lier RA, ten Berge IJ (2012) Cytomegalovirus-induced effector T cells cause endothelial cell damage. Clin Vaccine Immunol CVI 19(5):772–779. https://doi.org/10.1128/CVI.00011-12 CrossRefPubMed

32.

Betjes MG, Litjens NH, Zietse R (2007) Seropositivity for cytomegalovirus in patients with end-stage renal disease is strongly associated with atherosclerotic disease. Nephrol Dial Transplant 22(11):3298–3303. https://doi.org/10.1093/ndt/gfm348 CrossRefPubMed

33.

Buyukhatipoglu H, Tiryaki O, Tahta K, Usalan C (2007) Inflammation as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis in haemodialysis patients: the role of chlamydia and cytomegalovirus infection. Nephrology (Carlton) 12(1):25–32. https://doi.org/10.1111/j.1440-1797.2006.00742.x CrossRef

34.

Betjes MG, de Wit EE, Weimar W, Litjens NH (2010) Circulating pro-inflammatory CD4posCD28null T cells are independently associated with cardiovascular disease in ESRD patients. Nephrol Dial Transplant 25(11):3640–3646. https://doi.org/10.1093/ndt/gfq203 CrossRefPubMed

35.

Aiello AE, Chiu YL, Frasca D (2017) How does cytomegalovirus factor into diseases of aging and vaccine responses, and by what mechanisms? GeroScience 39(3):261–271. https://doi.org/10.1007/s11357-017-9983-9 CrossRefPubMedPubMedCentral

36.

Gomez-Mora E, Massanella M, Garcia E, Giles D, Bernado M, Urrea V, Carrillo J, Ouchi D, Puig J, Negredo E, Clotet B, Blanco J, Cabrera C (2017) Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery. PLoS One 12(9):e0184433. https://doi.org/10.1371/journal.pone.0184433 CrossRefPubMedPubMedCentral

37.

Mansfield SA, Dwivedi V, Elgharably H, Griessl M, Zimmerman PD, Limaye AP, Cook CH (2019) Cytomegalovirus immunoglobulin G titers do not predict reactivation risk in immunocompetent hosts. J Med Virol. https://doi.org/10.1002/jmv.25389 CrossRefPubMed

38.

Parry HM, Zuo J, Frumento G, Mirajkar N, Inman C, Edwards E, Griffiths M, Pratt G, Moss P (2016) Cytomegalovirus viral load within blood increases markedly in healthy people over the age of 70 years. Immun Ageing 13:1. https://doi.org/10.1186/s12979-015-0056-6 CrossRefPubMedPubMedCentral

39.

Yang FJ, Shu KH, Chen HY, Chen IY, Lay FY, Chuang YF, Wu CS, Tsai WC, Peng YS, Hsu SP, Chiang CK, Wang G, Chiu YL (2018) Anti-cytomegalovirus IgG antibody titer is positively associated with advanced T cell differentiation and coronary artery disease in end-stage renal disease. Immun Ageing 15:15. https://doi.org/10.1186/s12979-018-0120-0 CrossRefPubMedPubMedCentral

40.

Seder RA, Darrah PA, Roederer M (2008) T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 8(4):247–258. https://doi.org/10.1038/nri2274 CrossRefPubMed

41.

Larsen M, Sauce D, Arnaud L, Fastenackels S, Appay V, Gorochov G (2012) Evaluating cellular polyfunctionality with a novel polyfunctionality index. PLoS One 7(7):e42403. https://doi.org/10.1371/journal.pone.0042403 CrossRefPubMedPubMedCentral

42.

Wherry EJ (2011) T cell exhaustion. Nat Immunol 12(6):492–499CrossRef

43.

Migueles SA, Weeks KA, Nou E, Berkley AM, Rood JE, Osborne CM, Hallahan CW, Cogliano-Shutta NA, Metcalf JA, McLaughlin M, Kwan R, Mican JM, Davey RT Jr, Connors M (2009) Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy. J Virol 83(22):11876–11889. https://doi.org/10.1128/JVI.01153-09 CrossRefPubMedPubMedCentral

44.

Rodrigue-Gervais IG, Rigsby H, Jouan L, Sauve D, Sekaly RP, Willems B, Lamarre D (2010) Dendritic cell inhibition is connected to exhaustion of CD8+ T cell polyfunctionality during chronic hepatitis C virus infection. J Immunol 184(6):3134–3144. https://doi.org/10.4049/jimmunol.0902522 CrossRefPubMed

45.

Chiu YL, Lin CH, Sung BY, Chuang YF, Schneck JP, Kern F, Pawelec G, Wang GC (2016) Cytotoxic polyfunctionality maturation of cytomegalovirus-pp65-specific CD4+ and CD8+ T-cell responses in older adults positively correlates with response size. Sci Rep 6:19227. https://doi.org/10.1038/srep19227 CrossRefPubMedPubMedCentral

46.

Liu B, Carle KW, Whisler RL (1997) Reductions in the activation of ERK and JNK are associated with decreased IL-2 production in T cells from elderly humans stimulated by the TCR/CD3 complex and costimulatory signals. Cell Immunol 182(2):79–88CrossRef

47.

Ouyang Q, Wagner WM, Zheng W, Wikby A, Remarque EJ, Pawelec G (2004) Dysfunctional CMV-specific CD8(+) T cells accumulate in the elderly. Exp Gerontol 39(4):607–613. https://doi.org/10.1016/j.exger.2003.11.016 CrossRefPubMed

48.

Lelic A, Verschoor CP, Ventresca M, Parsons R, Evelegh C, Bowdish D, Betts MR, Loeb MB, Bramson JL (2012) The polyfunctionality of human memory CD8+ T cells elicited by acute and chronic virus infections is not influenced by age. PLoS Pathog 8(12):e1003076. https://doi.org/10.1371/journal.ppat.1003076 CrossRefPubMedPubMedCentral

49.

Van Epps P, Banks R, Aung H, Betts MR, Canaday DH (2014) Age-related differences in polyfunctional T cell responses. Immun Ageing 11:14. https://doi.org/10.1186/1742-4933-11-14 CrossRefPubMedPubMedCentral

50.

Bajwa M, Vita S, Vescovini R, Larsen M, Sansoni P, Terrazzini N, Caserta S, Thomas D, Davies KA, Smith H, Kern F (2016) Functional diversity of cytomegalovirus-specific T cells is maintained in older people and significantly associated with protein specificity and response size. J Infect Dis 214(9):1430–1437. https://doi.org/10.1093/infdis/jiw371 CrossRefPubMedPubMedCentral

51.

Huang L, Litjens NHR, Kannegieter NM, Klepper M, Baan CC, Betjes MGH (2017) pERK-dependent defective TCR-mediated activation of CD4(+) T cells in end-stage renal disease patients. Immun Ageing 14:14. https://doi.org/10.1186/s12979-017-0096-1 CrossRefPubMedPubMedCentral

Title: T-cell aging in end-stage renal disease: an evolving story with CMV
Authors: TienYu Owen Yang
Yi-Fang Chuang
Yen-Ling Chiu
Publication date: 01-08-2019
Publisher: Springer Berlin Heidelberg
Published in: Medical Microbiology and Immunology / Issue 3-4/2019
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI: https://doi.org/10.1007/s00430-019-00596-8

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

T-cell aging in end-stage renal disease: an evolving story with CMV

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3-4/2019

CD4 T cells are required for maintenance of CD8 TRM cells and virus control in the brain of MCMV-infected newborn mice

Pediatric roots of cytomegalovirus recurrence and memory inflation in the elderly

Kinetics of inflammatory biomarkers in plasma predict the occurrence and features of cytomegalovirus DNAemia episodes in allogeneic hematopoietic stem cell transplant recipients

‘Checks and balances’ in cytomegalovirus-host cohabitation

Role of antibodies in confining cytomegalovirus after reactivation from latency: three decades’ résumé

Caspase-8 restricts natural killer cell accumulation during MCMV Infection

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page